{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:38Z","timestamp":1793413958877,"version":"4.5.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jaclp.2024.10.004","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T01:06:41Z","timestamp":1731114401000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Zolpidem for the Management of Catatonia: A\u00a0Systematic Review"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7952-6782","authenticated-orcid":false,"given":"Matthew","family":"Gunther","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1440-4711","authenticated-orcid":false,"given":"Nathan","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaclp.2024.10.004_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2215-0366(18)30474-7","article-title":"Structure and neural mechanisms of catatonia","volume":"6","author":"Walther","year":"2019","journal-title":"Lancet Psychiatr"},{"key":"10.1016\/j.jaclp.2024.10.004_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.993671","article-title":"Molecular and cellular mechanisms leading to catatonia: an integrative approach from clinical and preclinical evidence","volume":"15","author":"Ariza-Salamanca","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.jaclp.2024.10.004_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5498\/wjp.v6.i4.391","article-title":"Catatonia: our current understanding of its diagnosis, treatment and pathophysiology","volume":"6","author":"Rasmussen","year":"2016","journal-title":"World J Psychiatry"},{"key":"10.1016\/j.jaclp.2024.10.004_bib4","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/00004714-198312000-00002","article-title":"Intravenous lorazepam in neuroleptic-induced catatonia","volume":"3","author":"Fricchione","year":"1983","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2024.10.004_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00004714-199002000-00024","article-title":"Lorazepam as an adjunct in the treatment of catatonic states: an open clinical trial","volume":"10","author":"Yassa","year":"1990","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.jaclp.2024.10.004_bib6","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1600-0447.1996.tb09815.x","article-title":"Catatonia. II. Treatment with lorazepam and electroconvulsive therapy","volume":"93","author":"Bush","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.jaclp.2024.10.004_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2017.06.011","article-title":"Alternative treatment strategies for catatonia: a systematic review","volume":"48","author":"Beach","year":"2017","journal-title":"Gen Hosp Psychiatr"},{"key":"10.1016\/j.jaclp.2024.10.004_bib8","first-page":"52","article-title":"[Favourable effect of zolpidem on catatonia]","volume":"151","author":"Mastain","year":"1995","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.jaclp.2024.10.004_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.schres.2023.02.015","article-title":"Lorazepam in catatonia \u2013 past, present and future of a clinical success story","volume":"263","author":"Hirjak","year":"2024","journal-title":"Schizophr Res"},{"key":"10.1016\/j.jaclp.2024.10.004_bib10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fpsyt.2014.00181","article-title":"A\u00a0clinical review of the treatment of catatonia","volume":"5","author":"Sienaert","year":"2014","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.jaclp.2024.10.004_bib11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/schbul\/sbp141","article-title":"Catatonia and its treatment","volume":"36","author":"Rosebush","year":"2010","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.jaclp.2024.10.004_bib12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00000542-200601000-00005","article-title":"Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients","volume":"104","author":"Pandharipande","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jaclp.2024.10.004_bib13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1212\/WNL.0000000000001326","article-title":"Antibodies to GABAA receptor \u03b11 and \u03b32 subunits: clinical and serologic characterization","volume":"84","author":"Pettingill","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jaclp.2024.10.004_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1136\/practneurol-2019-002388","article-title":"Catatonia with GABAA receptor antibodies","volume":"20","author":"Samra","year":"2020","journal-title":"Practical Neurol"},{"key":"10.1016\/j.jaclp.2024.10.004_bib16","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","article-title":"Different GABA A receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates","volume":"102","author":"Rowlett","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jaclp.2024.10.004_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s43141-021-00224-0","article-title":"GABAA receptors: structure, function, pharmacology, and related disorders","volume":"19","author":"Ghit","year":"2021","journal-title":"J\u00a0Genet Eng Biotechnol"},{"key":"10.1016\/j.jaclp.2024.10.004_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.877566","article-title":"Catatonia and cognitive impairments: a systematic review","volume":"13","author":"Serrat","year":"2022","journal-title":"Front Psychiatr"},{"key":"10.1016\/j.jaclp.2024.10.004_bib20","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1213\/ANE.0000000000000201","article-title":"Benzodiazepine site agonists differentially alter acetylcholine release in Rat amygdala","volume":"118","author":"Hambrecht-Wiedbusch","year":"2014","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jaclp.2024.10.004_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2004.12.016","article-title":"Acetylcholine in the accumbens is decreased by diazepam and increased by benzodiazepine withdrawal: a possible mechanism for dependency","volume":"508","author":"Rada","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jaclp.2024.10.004_bib22","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1590\/1980-57642021dn15-030013","article-title":"Cognitive and balance dysfunctions due to the use of zolpidem in the elderly: a systematic review","volume":"15","author":"Tavares","year":"2021","journal-title":"Dement Neuropsychol"},{"key":"10.1016\/j.jaclp.2024.10.004_bib23","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jamaneurol.2017.1133","article-title":"Zolpidem for the treatment of neurologic disorders: a systematic review","volume":"74","author":"Bomalaski","year":"2017","journal-title":"JAMA Neurol"}],"container-title":["Journal of the Academy of Consultation-Liaison Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667296024001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T17:44:20Z","timestamp":1741628660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667296024001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2667296024001149"],"URL":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.10.004","relation":{},"ISSN":["2667-2960"],"issn-type":[{"value":"2667-2960","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zolpidem for the Management of Catatonia: A\u00a0Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of the Academy of Consultation-Liaison Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaclp.2024.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Academy of Consultation-Liaison Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}